Eimskip: Major shareholder announcement from Stefnir
Tweet
Share
E-mail
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
- ITM and Lumara Bio Announce Real-World Re-treatment Data and Dosimetry Results from COMPETE for ¹⁷⁷Luedotreotide (ITM-11) in GEP-NETs at ASTRO 2026
- HBAR Price Prediction: Could Hedera Reach $1 or Will Remittix’s New Dashboard Draw the Next Wave?
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
EIM GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
